Did not become law. It stopped in the Senate's Aging Committee on March 4, 2022. The 2022 session has ended.
2022 Regular Session
Senate Bill 260
AN ACT CONCERNING A PRESCRIPTION DRUG COST CONTROL BOARD.
What it does
The synopsis the General Assembly published with the bill.
To establish a board with authority to monitor prescription drug costs and recommend price caps on such drugs sold in the state.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
In the House of Representatives
4 co-sponsors
Michael A. Winkler, Christine Palm, Anthony L. Nolan, Brian T. Smith
Its course
March 3 to March 4, 2022, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action2 actions on 2 days
In the SenateMar 3 to Mar 4 · stopped1 day
Aging CommitteeMar 3 to Mar 4 · stopped1 day
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Mar 3 – Mar 4
- Mar 3Introduced and sent to Aging Committee
- Mar 4Heard in Aging Committee
All 2 actions, as published
- Mar 3REF. TO JOINT COMM. ONBoth houses
- Mar 4PUBLIC HEARINGBoth houses